Trial intelligence / Profile preview

Reductrauma: Propranolol for PTSD Memory Reconsolidation

NCT00465608Phase 2Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Apr 2007
Primary completion
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: PTSD Checklist at 3 months. Started Apr 2007; status: completed.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT00465608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00465608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call